• GI 254023X: A Selective ADAM10 Inhibitor

  2026-09-02

  GI 254023X provides a practical way to separate ADAM10 sheddase activity from closely related ADAM17 biology in endothelial-barrier and Jurkat-cell experiments. Its value is strongest when target engagement is paired with functional readouts, dose-response design, and the moderate-effect logic highlighted by neurobiology research.

• Superoxide Dismutase Activity Assay Kit Workflow

  2026-09-01

  Build a fast, colorimetric SOD Activity Assay workflow around matrix controls, dilution linearity, and wavelength-specific quality checks. The approach is especially useful for oxidative stress assay development, where SOD activity must be distinguished from direct hydrogen peroxide measurements and probe-specific artifacts.

• Partial BACE Inhibition Preserves Synaptic Transmission

  2026-09-01

  Satir et al. show that modest β-secretase inhibition can reduce amyloid β secretion by up to approximately 50% without measurable impairment of synaptic transmission in cultured rat cortical neurons. The study identifies a dose-dependent separation between potentially useful amyloid reduction and synaptic dysfunction, providing a practical framework for interpreting BACE inhibitor exposure in Alzheimer’s disease prevention studies.

• Lactate–HMGB1 Signaling in Polymicrobial Sepsis

  2026-08-31

  Yang and colleagues identified lactate as an active regulator of macrophage HMGB1 release rather than only a biomarker of severe sepsis. Their work links lactate uptake to HMGB1 lactylation, acetylation, exosomal secretion, endothelial permeability, and survival in polymicrobial sepsis, providing a mechanistic framework for inflammatory signaling pathway research.

• Itraconazole for Candida Biofilm Assays

  2026-08-31

  Itraconazole is a triazole antifungal agent with value beyond growth inhibition. This guide shows how to use its CYP3A4, autophagy, and biofilm-relevant biology to design more discriminating Candida resistance assays.

• circHIF1A Axis and M2 Polarization in LUAD

  2026-08-30

  This study identifies a circHIF1A/miR-486-5p/GRHL2 regulatory axis that connects malignant behavior in lung adenocarcinoma cells with IL-10-associated macrophage M2 polarization. Its combined patient, cellular, and xenograft evidence supports circHIF1A as a candidate prognostic biomarker and highlights circular RNA-mediated remodeling of the tumor immune microenvironment.

• Radiotherapy, PD-1 and TIGIT Blockade in Tumor Immunity

  2026-08-29

  The reference study shows that radiotherapy combined with PD-1 and TIGIT blockade can control both irradiated and distant tumors while establishing durable CD8+ T-cell-mediated immune memory. Its integrated use of syngeneic bilateral tumor models, immune profiling, single-cell transcriptomics, cytokine analysis, rechallenge, and adoptive transfer clarifies how activated macrophages and CD8+ T cells cooperate during the abscopal response.

• Wortmannin: PI3K Inhibitor Workflow Guide

  2026-08-28

  Wortmannin combines nanomolar PI3K potency with irreversible target engagement, making it useful for dissecting PI3K/Akt/mTOR signaling, autophagy, apoptosis, and host–pathogen entry. This practical guide translates its inhibitor profile into cell-based workflows, viral-entry assays, cancer research models, and troubleshooting strategies.

• BMN 673 and the New Logic of PARP Trapping

  2026-08-28

  BMN 673 (Talazoparib) offers translational researchers more than catalytic PARP inhibition: its strong PARP-DNA complex trapping creates a mechanistic lens for studying BRCA2-RAD51 protection, homologous recombination deficiency, biomarker selection, and combination strategy.

• RP3-340N1.2, IL-6, and NSCLC Progression

  2026-08-27

  The reference study identifies the lncRNA RP3-340N1.2 as a regulator of IL-6 mRNA stability in non-small cell lung cancer. Its knockdown strengthens ZC3H12A association with IL-6 mRNA, accelerates transcript degradation, and suppresses tumor-cell proliferation, migration, and tumor-associated macrophage polarization.

• AP20187: Designing Better Dimerization Assays

  2026-08-27

  AP20187 is a chemical inducer of dimerization that enables conditional control of engineered signaling proteins. This guide focuses on assay architecture, biological interpretation, and control selection rather than repeating standard application claims.

• Olaparib and the Hidden Logic of BRCA2 Repair

  2026-08-26

  Olaparib and its research alias AZD2281 are more than PARP inhibitors for viability screens: emerging evidence positions them as probes of nascent-strand maturation, BRCA2-dependent gap repair, and replication-associated DNA damage. This thought-leadership guide translates that mechanism into practical assay design, radiosensitization strategy, and biomarker-aware cancer research.

• Caffeine in Translational Research: Mechanism to Strategy

  2026-08-26

  Caffeine and 1,3,7-trimethylpurine-2,6-dione offer a versatile framework for studying adenosine signaling, cancer cell line inhibition, and energy metabolism modulation. This thought-leadership guide connects assay design, diet-induced obesity mouse model evidence, and enzyme-targeted translational strategy to help researchers move from compound activity to defensible biological conclusions.

• CCK-8 and Opioid-Dependent Anxiolysis

  2026-08-25

  A 2014 Neuroscience study found that centrally administered CCK-8 reduced anxiety-like behavior during morphine withdrawal in rats through a CCK1 receptor– and endogenous opioid–dependent mechanism. The work separates the anxiolytic action of CCK-8 from the anxiety-promoting effects often associated with other CCK peptides and provides a receptor-focused framework for withdrawal research.

• Triazole ALDH2 Activators Protect Ischemic Heart

  2026-08-25

  The 2025 ACS Medicinal Chemistry Letters study describes triazole-based aldehyde dehydrogenase 2 (ALDH2) activators designed to improve both enzyme activation and aqueous solubility. Lead compound Z17 produced strong ALDH2 activation and improved cardiac function, infarct burden, and injury biomarkers in a mouse myocardial ischemia-reperfusion model.

7908 records 1/528 page Next 12345 下5页 Last page